Andrew Craig Miller - 10 Nov 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Operating Officer
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 10 Nov 2022
Net transactions value: -$3,379,510
Form type: 4
Filing time: 14 Nov 2022, 15:21:45 UTC
Previous filing: 03 Nov 2022
Next filing: 02 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$7,270	+1,000	+2.6%	$7.27^*	39,500	11 Nov 2022	Direct
transaction	KRTX	Common Stock	Options Exercise	$2,920	+1,000	+2.5%	$2.92^*	40,500	11 Nov 2022	Direct
transaction	KRTX	Common Stock	Sale	$3,389,700	-15,000	-37%	$225.98	25,500	10 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-1,000	-7.8%	$0.000000	11,828	11 Nov 2022	Common Stock	1,000	$7.27	Direct	F2
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-1,000	-1.8%	$0.000000	55,417	11 Nov 2022	Common Stock	1,000	$2.92	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2022.
F2	This option vested as to 1/30th of the shares underlying the option award on each one month anniversary of the vesting commencement date of August 15, 2018.
F3	This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.